HIV‐associated Burkitt lymphoma in the combination antiretroviral therapy era: Real‐world outcomes and prognostication-Reference-Cited by-同舟云学术

HIV‐associated Burkitt lymphoma in the combination antiretroviral therapy era: Real‐world outcomes and prognostication

Published:2022-12-15 Issue:1 Volume:4 Page:100-107
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Wang Chaoyu¹,Liang Shunsi¹,Quan Xi¹,Guo Bingling¹,Huang Dehong¹,Li Jieping¹,Liu Yao¹

Affiliation:

1. Department of Hematology Oncology Chongqing University Cancer Hospital Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment Chongqing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.624

Reference21 articles.

1. Progress in the Treatment of HIV-Associated Lymphoma When Combined With the Antiretroviral Therapies

2. HIV-Associated Cancers and Related Diseases

3. Clinical characteristics and outcomes of newly diagnosed patients with HIV ‐associated aggressive B‐cell NHL in China

4. The treatment of Burkitt lymphoma in adults

5. Epidemiology of haematological malignancies in people living with HIV

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: results of a multicenter study from China;Infectious Agents and Cancer;2024-04-15

2. Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: results of a multicenter study from China;2024-01-02

3. Identifying Factors Affecting the Survival of Patients with HIV-Associated B-Cell Lymphoma Using a Random Survival Forest Model;Clinical Medicine Insights: Oncology;2024-01

4. Readmission rates in HIV-associated burkitt lymphoma patients in the USA: a nationwide readmission database (NRD) analysis;AIDS Research and Therapy;2023-11-11

5. Readmission rates in HIV-associated Burkitt lymphoma patients: A nationwide readmission database (NRD) analysis;2023-08-23